June 9, 2014
Medicare beneficiaries and patient advocates breathed a collective sigh of relief last month when the Centers for Medicare and Medicaid Services (CMS) issued its final Part D rule – which targeted program abuse instead of implementing cost-cutting restrictions on medication access.
May 29, 2014
What’s in a name? A lot, as the Food and Drug Administration and World Health Organization are discovering.
May 27, 2014
The Food and Drug Administration may require less clinical data to approve biosimilars (imitations of powerful biological medications).
May 23, 2014
By David Charles, MD and Mary Ann Chapman, PhD If requiring biological medications to have unique names would help ensure…
April 7, 2014
Biologics are the fastest growing segment of new medical breakthroughs.
April 4, 2014
Over the past several years, in response to campaigns by the AAN and state neurology societies, a growing number of states have passed laws prohibiting pharmacists from substituting one generic version of an antiepileptic drug (AED) for another without notifying the physician.
March 28, 2014
Imagine seeing a patient who was once dependent upon a cane begin to move about unassisted.
March 27, 2014
Indiana Governor Mike Pence this week signed Senate Bill 262, a bill on biosimilar drugs that allows substitution if certain conditions are met.
March 20, 2014
The Alliance for Safe Biologics and EuropaBio recently released results of a survey of 470 European physicians’ views on biosimilar naming.
February 7, 2014
Recently two World Health Organization resolutions were approved for consideration at the 67th World Health Assembly, to convene this coming May in Geneva.
